{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T06:41:26Z","timestamp":1792737686424,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100017950","name":"Shanghai Municipal Health Commission","doi-asserted-by":"publisher","award":["20244Y0003"],"award-info":[{"award-number":["20244Y0003"]}],"id":[{"id":"10.13039\/100017950","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"publisher","award":["2026J0011895"],"award-info":[{"award-number":["2026J0011895"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010814","name":"Anhui Provincial Department of Education","doi-asserted-by":"publisher","award":["DTR2024028"],"award-info":[{"award-number":["DTR2024028"]}],"id":[{"id":"10.13039\/501100010814","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejradiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Radiology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ejrad.2026.113228","type":"journal-article","created":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T23:24:42Z","timestamp":1788823482000},"page":"113228","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A biologically Interpretable CT radiomic model Predicts tertiary lymphoid structure status and Stratifies outcomes following chemoimmunotherapy in pancreatic ductal adenocarcinoma"],"prefix":"10.1016","volume":"205","author":[{"given":"Cancan","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuyi","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingcheng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjian","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiwu","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengsu","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuyang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiying","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minping","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongyu","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4734-9683","authenticated-orcid":false,"given":"Haitao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejrad.2026.113228_b0005","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/S0140-6736(25)00261-2","article-title":"Pancreatic cancer","volume":"405","author":"Stoop","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.ejrad.2026.113228_b0010","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.gtc.2024.09.006","article-title":"Pancreatic cancer: screening and early detection","volume":"54","author":"Mohamed","year":"2025","journal-title":"Gastroenterol. Clin. North Am."},{"key":"10.1016\/j.ejrad.2026.113228_b0015","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1200\/OP.24.00279","article-title":"Novel therapies for pancreatic cancer","volume":"21","author":"Chung","year":"2025","journal-title":"JCO Oncol Pract"},{"key":"10.1016\/j.ejrad.2026.113228_b0020","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/ueg2.12701","article-title":"Organoid-based precision medicine in pancreatic cancer","volume":"13","author":"Beutel","year":"2025","journal-title":"United European Gastroenterol J"},{"key":"10.1016\/j.ejrad.2026.113228_b0025","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1001\/jamaoncol.2019.1588","article-title":"Durvalumab with or without tremelimumab for patients with metastatic pancreatic ductal adenocarcinoma: a phase 2 randomized clinical trial","volume":"5","author":"O'Reilly","year":"2019","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.ejrad.2026.113228_b0030","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/s41571-025-01019-9","article-title":"Improving outcomes of patients with pancreatic cancer","volume":"22","author":"Dreyer","year":"2025","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ejrad.2026.113228_b0035","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.21873\/anticanres.17519","article-title":"Adjuvant treatment for resectable pancreatic cancer","volume":"45","author":"Aoyama","year":"2025","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ejrad.2026.113228_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217350","article-title":"Frontiers in pancreatic cancer on biomarkers, microenvironment, and immunotherapy","volume":"610","author":"Yu","year":"2025","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ejrad.2026.113228_b0045","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.it.2014.09.006","article-title":"Tertiary lymphoid structures in cancer and beyond","volume":"35","author":"Dieu-Nosjean","year":"2014","journal-title":"Trends Immunol."},{"key":"10.1016\/j.ejrad.2026.113228_b0050","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1002\/cac2.12373","article-title":"The diagnosis, classification, and treatment of sarcoma in this era of artificial intelligence and immunotherapy","volume":"42","author":"Cromb\u00e9","year":"2022","journal-title":"Cancer Commun (lond)"},{"key":"10.1016\/j.ejrad.2026.113228_b0055","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/s41586-019-1914-8","article-title":"Tertiary lymphoid structures improve immunotherapy and survival in melanoma","volume":"577","author":"Cabrita","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ejrad.2026.113228_b0060","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/s41586-019-1922-8","article-title":"B cells and tertiary lymphoid structures promote immunotherapy response","volume":"577","author":"Helmink","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ejrad.2026.113228_b0065","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-006698","article-title":"Characterization of intratumoral tertiary lymphoid structures in pancreatic ductal adenocarcinoma: cellular properties and prognostic significance","volume":"11","author":"Zou","year":"2023","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.ejrad.2026.113228_b0070","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/s41568-019-0144-6","article-title":"Tertiary lymphoid structures in the era of cancer immunotherapy","volume":"19","author":"Saut\u00e8s-Fridman","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejrad.2026.113228_b0075","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1097\/JS9.0000000000002059","article-title":"Development and validation of a CT-based radiomics model to predict survival-graded fibrosis in pancreatic ductal adenocarcinoma","volume":"111","author":"Shi","year":"2025","journal-title":"Int. J. Surg."},{"key":"10.1016\/j.ejrad.2026.113228_b0080","article-title":"Habitat radiomics predicts occult lymph node metastasis and uncovers immune microenvironment of head and neck cancer","volume":"23","author":"Chen","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.ejrad.2026.113228_b0085","doi-asserted-by":"crossref","first-page":"5158","DOI":"10.1007\/s00330-020-06853-2","article-title":"Pancreatic adenocarcinoma: quantitative CT features are correlated with fibrous stromal fraction and help predict outcome after resection","volume":"30","author":"Cai","year":"2020","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.ejrad.2026.113228_b0090","doi-asserted-by":"crossref","first-page":"10533","DOI":"10.1038\/s41598-025-94684-w","article-title":"Radiomic features at contrast-enhanced CT predict proliferative hepatocellular carcinoma and its prognosis after transarterial chemoembolization","volume":"15","author":"He","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejrad.2026.113228_b0095","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/s43018-021-00232-6","article-title":"Mature tertiary lymphoid structures predict immune checkpoint inhibitor efficacy in solid tumors independently of PD-l1 expression","volume":"2","author":"Vanhersecke","year":"2021","journal-title":"Nat Cancer"},{"key":"10.1016\/j.ejrad.2026.113228_b0100","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s40644-024-00813-5","article-title":"Preoperative assessment of tertiary lymphoid structures in stage i lung adenocarcinoma using CT radiomics: a multicenter retrospective cohort study","volume":"24","author":"Zhao","year":"2024","journal-title":"Cancer Imaging"},{"key":"10.1016\/j.ejrad.2026.113228_b0105","doi-asserted-by":"crossref","DOI":"10.1186\/s13244-023-01527-1","article-title":"A CT-based radiomics approach to predict intra-tumoral tertiary lymphoid structures and recurrence of intrahepatic cholangiocarcinoma","volume":"14","author":"Xu","year":"2023","journal-title":"Insights Imaging"},{"key":"10.1016\/j.ejrad.2026.113228_b0110","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-009879","article-title":"Spatial patterns and MRI-based radiomic prediction of high peritumoral tertiary lymphoid structure density in hepatocellular carcinoma: a multicenter study","volume":"12","author":"Long","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.ejrad.2026.113228_b0115","doi-asserted-by":"crossref","first-page":"4800","DOI":"10.1007\/s00261-021-03159-9","article-title":"Machine learning for MRI radiomics: a study predicting tumor-infiltrating lymphocytes in patients with pancreatic ductal adenocarcinoma","volume":"46","author":"Bian","year":"2021","journal-title":"Abdom Radiol (NY)"},{"key":"10.1016\/j.ejrad.2026.113228_b0120","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adf0837","article-title":"Radiogenomic-based multiomic analysis reveals imaging intratumor heterogeneity phenotypes and therapeutic targets","volume":"9","author":"Su","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ejrad.2026.113228_b0125","doi-asserted-by":"crossref","first-page":"935","DOI":"10.3350\/cmh.2024.0895","article-title":"Radiogenomics of intrahepatic cholangiocarcinoma predicts immunochemotherapy response and identifies therapeutic target","volume":"31","author":"Ji","year":"2025","journal-title":"Clin. Mol. Hepatol."},{"key":"10.1016\/j.ejrad.2026.113228_b0130","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-40850-5","article-title":"Desmoplastic stroma restricts t cell extravasation and mediates immune exclusion and immunosuppression in solid tumors","volume":"14","author":"Xiao","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejrad.2026.113228_b0135","article-title":"Beyond just a tight fortress: contribution of stroma to epithelial-mesenchymal transition in pancreatic cancer","volume":"5","author":"Bulle","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ejrad.2026.113228_b0140","article-title":"Translational and oncologic significance of tertiary lymphoid structures in pancreatic adenocarcinoma","volume":"15","author":"Gao","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejrad.2026.113228_b0145","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1222719","article-title":"Tertiary lymphoid structures in pancreatic cancer: a new target for immunotherapy","volume":"14","author":"Zou","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejrad.2026.113228_b0150","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1136\/gutjnl-2022-328697","article-title":"Mature tertiary lymphoid structures are key niches of tumour-specific immune responses in pancreatic ductal adenocarcinomas","volume":"72","author":"Kinker","year":"2023","journal-title":"Gut"}],"container-title":["European Journal of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X26005760?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X26005760?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T06:35:01Z","timestamp":1792737301000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0720048X26005760"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":30,"alternative-id":["S0720048X26005760"],"URL":"https:\/\/doi.org\/10.1016\/j.ejrad.2026.113228","relation":{},"ISSN":["0720-048X"],"issn-type":[{"value":"0720-048X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A biologically Interpretable CT radiomic model Predicts tertiary lymphoid structure status and Stratifies outcomes following chemoimmunotherapy in pancreatic ductal adenocarcinoma","name":"articletitle","label":"Article Title"},{"value":"European Journal of Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejrad.2026.113228","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"113228"}}